Cytogenetic abnormalities and clinical outcome in Wilms tumor: A study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group†
Authors:
- Nick BownNBNick Bown
- Simon J. CotterillSCSimon J. Cotterill
- Paul RobertsPRPaul Roberts
- Mike GriffithsMGMike Griffiths
- Simon LarkinsSLSimon Larkins
- Steve HibbertSHSteve Hibbert
- Helen MiddletonHMHelen Middleton
- Anna KelseyAKAnna Kelsey
- Denise TrittonDTDenise Tritton
- Chris MitchellCMChris Mitchell
- 21 December 2001
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 38 (1) , 11-21
Abstract
Background: Tumor genetic features reported to correlate with adverse outcome in Wilms tumor include karyotype complexity, losses of material from the short arm of chromosome 1 and from the long arms of chromosomes 11, 16 and 22 and gain of material from the long arm of chromosome 1. This study sought to test these associations in a large series of tumors studied by cytogenetic analysis. Identification of markers associated with elevated risk of relapse and fatal outcome could allow more effective treatment stratification at presentation.Procedure: Thirteen member laboratories of the U.K. Cancer Cytogenetics Group provided results from a 12‐year period. Karyotype abnormalities were correlated with clinical data (age, tumor stage, and histology) and outcome data provided by the central register of the U.K. Children's Cancer Study Group.Results: Of 127 abnormal karyotypes, 78 included a reputedly “poor prognosis” feature. Univariate survival analysis showed no significant adverse effect for karyotype complexity, 1p loss or 11q loss. The poor outcome of cases with 16q loss was of borderline significance, but this effect was restricted to those tumors with unbalanced translocation der(16)t(1q;16q). The association between relapse risk and gain of 1q material was not significant. Only monosomy 22 was a significant marker of poor outcome in univariate analysis (13 cases showing 50% relapse free survival at 5 years compared to 79% survival for the remaining 114 cases, P = 0.02). In multivariate analysis, significant independent predictors of poor outcome were 1q gain (Hazard Ratio 3.4), stage IV disease (HR 5.0), and monosomy 22 (HR 5.9).Conclusions: Loss of chromosome 22 identifies high risk Wilms tumors. The prognostic significance of 1q gain, 16q loss and unbalanced translocation der(16)t(1q;16q) is unresolved and warrants further investigation. Med Pediatr Oncol 2002;38:11–21.Keywords
This publication has 21 references indexed in Scilit:
- Gain of 1q Is Associated with Adverse Outcome in Favorable Histology Wilms’ TumorsThe American Journal of Pathology, 2001
- The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour studyBritish Journal of Cancer, 2000
- High Frequency of Loss of Heterozygosity for 1p35–p36 (D1S247) in Wilms TumorCancer Genetics and Cytogenetics, 2000
- 16q heterozygosity loss in Wilms» tumour in children and its clinical importanceEuropean Journal of Surgical Oncology, 2000
- Hemizygous Deletions of Chromosome Band 16q24 in Wilms TumorCancer Genetics and Cytogenetics, 1999
- Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parametersGenes, Chromosomes and Cancer, 1998
- Comparative genomic hybridization analysis of Wilms tumorsCytogenetic and Genome Research, 1997
- Childhood cancer in Britain: The National Registry of Childhood Tumours and incidence rates 1978–1987European Journal of Cancer, 1995
- Cytogenetics and molecular genetics of Wilms' Tumor of childhoodCancer Genetics and Cytogenetics, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958